ROSEN, A LEADING LAW FIRM, Encourages Rentokil Initial plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – RTO

Core Viewpoint - Rosen Law Firm is reminding purchasers of American Depositary Shares (ADS) of Rentokil Initial plc about the upcoming lead plaintiff deadline for a class action lawsuit related to alleged misleading statements and execution challenges during the integration of Terminix [1][5]. Group 1: Class Action Details - The class period for the lawsuit is from December 1, 2023, to September 10, 2024, and the lead plaintiff deadline is January 27, 2025 [1]. - Investors who purchased Rentokil ADSs during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. Group 2: Allegations Against Rentokil - The lawsuit alleges that Rentokil made false and misleading statements regarding the integration of Terminix, including significant disruption and execution challenges that negatively impacted business operations and organic revenue growth in North America [5]. - Specific claims include that Rentokil and Terminix remained separate businesses and that the integration plan was imperiled due to these challenges [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [4].